Literature DB >> 19479945

Role of hypoxia in the hallmarks of human cancer.

Kai Ruan1, Gang Song, Gaoliang Ouyang.   

Abstract

Hypoxia has been recognized as one of the fundamentally important features of solid tumors and plays a critical role in various cellular and physiologic events, including cell proliferation, survival, angiogenesis, immunosurveillance, metabolism, as well as tumor invasion and metastasis. These responses to hypoxia are at least partially orchestrated by activation of the hypoxia-inducible factors (HIFs). HIF-1 is a key regulator of the response of mammalian cells to oxygen deprivation and plays critical roles in the adaptation of tumor cells to a hypoxic microenvironment. Hypoxia and overexpression of HIF-1 have been associated with radiation therapy and chemotherapy resistance, an increased risk of invasion and metastasis, and a poor clinical prognosis of solid tumors. The discovery of HIF-1 signaling has led to a rapidly increasing understanding of the complex mechanisms involved in tumor hypoxia and has helped greatly in screening novel anticancer agents. In this review, we will first introduce the cellular responses to hypoxia and HIF-1 signaling pathway in hypoxia, and then summarize the multifaceted role of hypoxia in the hallmarks of human cancers. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479945     DOI: 10.1002/jcb.22214

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  175 in total

Review 1.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

2.  Chemical genetics analysis of an aniline mustard anticancer agent reveals complex I of the electron transport chain as a target.

Authors:  Bogdan I Fedeles; Angela Y Zhu; Kellie S Young; Shawn M Hillier; Kyle D Proffitt; John M Essigmann; Robert G Croy
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 3.  Role of hyperoxic treatment in cancer.

Authors:  Sei W Kim; In K Kim; Sang H Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

Review 4.  The multiple facets of periostin in bone metabolism.

Authors:  B Merle; P Garnero
Journal:  Osteoporos Int       Date:  2012-02-07       Impact factor: 4.507

5.  Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.

Authors:  Junqiang Tian; Hongjuan Zhao; Rosalie Nolley; Stephen W Reese; Sarah R Young; Xuejun Li; Donna M Peehl; Susan J Knox
Journal:  Clin Cancer Res       Date:  2012-04-25       Impact factor: 12.531

6.  Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.

Authors:  Caixia Tang; Hu Lei; Jinfu Zhang; Meng Liu; Jin Jin; Hao Luo; Hanzhang Xu; Yingli Wu
Journal:  Cancer Biol Ther       Date:  2018-05-08       Impact factor: 4.742

Review 7.  The association between the rs11549465 polymorphism in the hif-1α gene and cancer risk: a meta-analysis.

Authors:  Yujie Li; Chunyan Li; Hui Shi; Lieming Lou; Pengcheng Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

8.  Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

Authors:  Matthias Choschzick; Linn Woelber; Stephan Hess; Christine zu Eulenburg; Jörg Schwarz; Ronald Simon; Sven Mahner; Fritz Jaenicke; Volkmar Müller
Journal:  Virchows Arch       Date:  2010-04-01       Impact factor: 4.064

9.  Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ.

Authors:  Moacyr Jesus Barreto de Melo Rêgo; Gabriela Souto Vieira de Mello; Carlos André da Silva Santos; Roger Chammas; Eduardo Isidoro Carneiro Beltrão
Journal:  Med Mol Morphol       Date:  2013-02-05       Impact factor: 2.309

10.  Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.

Authors:  Y Xi; Y Wei; B Sennino; A Ulsamer; I Kwan; A N Brumwell; K Tan; M K Aghi; D M McDonald; D M Jablons; H A Chapman
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.